Vitamin Shoppe (VSI) Tops Q3 EPS by 9c, Revenues Miss

Vitamin Shoppe (NYSE: VSI) reported Q3 EPS of $0.04, $0.09 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $276.64 million versus the consensus estimate of $280.1 million.

Commenting on the quarter's results, Sharon Leite, CEO stated, "The team is making progress against the priorities outlined earlier this year. Sales and margins are improving and the organization is steadfast in our ability to improve these metrics further. Progress has also been made with our vendors, which has allowed us to test new categories as well as bring new and exclusive products to market."

"I am delighted to be a part of The Vitamin Shoppe organization. We will be taking transformative, strategic actions to expeditiously turn around the company and position us to drive sustainable growth. The team has made progress as evidenced by our achievements to date, however there is still much more work to do" concluded Ms. Leite.

For earnings history and earnings-related data on Vitamin Shoppe (VSI) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c